Close Menu

NEW YORK (GenomeWeb) – Roche said today that it has received the CE IVD mark for its Cobas HPV assay on the Cobas 6800/8800 systems for cervical cancer screening.

Cobas HPV is a real-time PCR test that provides specific genotyping information for human papillomavirus 16 and 18, the highest-risk types, while simultaneously reporting the 12 other high-risk HPV types as a pooled result.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.